We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,954 results
  1. Fabry App: the value of a portable technology in recording day-to-day patient monitored information in patients with Fabry disease

    Background

    Fabry disease is a rare inherited disorder resulting from deficient α-galactosidase A enzyme activity. Common disease manifestations are...

    Simona D’Amore, Mark Mckie, ... Uma Ramaswami in Orphanet Journal of Rare Diseases
    Article Open access 11 January 2024
  2. Oxidative stress and its role in Fabry disease

    Fabry disease is a rare X-linked disease characterized by deficient expression and activity of alpha-galactosidase A with consequent lysosomal...

    Martina Cacciapuoti, Giovanni Bertoldi, ... Lorenzo A. Calò in Journal of Nephrology
    Article 15 June 2024
  3. Fabry Disease: Cardiac Implications and Molecular Mechanisms

    Purpose of Review

    This review explores the interplay among metabolic dysfunction, oxidative stress, inflammation, and fibrosis in Fabry disease,...

    David Weissman, Jan Dudek, ... Christoph Maack in Current Heart Failure Reports
    Article Open access 30 January 2024
  4. Increased prevalence of peripheral vestibular disorder among patients with Fabry disease

    Background

    Although peripheral vestibular disorder is a non-fatal complication of Fabry disease, fatalities have been reported in some case reports...

    Tzong-Hann Yang, Sudha **rasagar, ... Herng-Ching Lin in Orphanet Journal of Rare Diseases
    Article Open access 02 March 2024
  5. Outcomes and management of kidney transplant recipients with Fabry disease: a review

    Abstract

    Fabry disease is an X-linked inheritable lysosomal storage disease caused by various mutations of the galactosidase α gene resulting in...

    Bo Yu, Mohamed G. Atta, ... Sam Kant in Journal of Nephrology
    Article 16 January 2024
  6. Amyloidosis and Fabry Disease A Clinical Guide

    This book presents a multispecialty and multidisciplinary approach on Amyloidosis and Fabry disease. These two “rare” diseases are underdiagnosed and...

    Diane Xavier de Ávila, Humberto Villacorta Junior
    Book 2023
  7. Pregnancy outcomes of Fabry disease in Austria (PROFABIA)-a retrospective cohort-study

    Background

    Pregnancy and delivery outcomes in women with Fabry disease are not well described.

    Methods

    Retrospective cohort-study of women with Fabry...

    Natalja Haninger-Vacariu, Kyra Anastopoulos, ... Alice Schmidt in Orphanet Journal of Rare Diseases
    Article Open access 18 April 2024
  8. Pathogenic pathways of renal damage in Fabry nephropathy: interplay between immune cell infiltration, apoptosis and fibrosis

    Background

    Fabry nephropathy is a consequence of the deposition of globotriaosylceramide, caused by deficient GLA enzyme activity in all types of...

    Constanza Bondar, Maria de los Angeles de Bolla, ... Paula Adriana Rozenfeld in Journal of Nephrology
    Article 21 March 2024
  9. Neurootologische Manifestationen bei Morbus Fabry – eine retrospektive Analyse

    Background

    Fabry disease (FD) is one of the X‑linked lysosomal storage diseases that can affect any organ. They have a specific lysosomal dysfunction...

    Katharina Storck, Anna Stenzl, ... Andreas Knopf in HNO
    Article Open access 25 September 2023
  10. Diagnosing Fabry nephropathy: the challenge of multiple kidney disease

    Fabry disease (FD) is an X-linked inherited lysosomal disorder due to a deficiency of the enzyme alpha-galactosidase A (α-gla) due to mutations in...

    Pasquale Esposito, Carmela Caputo, ... Francesca Viazzi in BMC Nephrology
    Article Open access 21 November 2023
  11. Morbus Fabry

    Fabry disease is an inherited X‑linked lysosomal storage disorder of the glycosphingolipid metabolic pathway. The enzyme activity of...

    Sabine Horn in psychopraxis. neuropraxis
    Article 14 July 2022
  12. Arrhythmogenesis in Fabry Disease

    Purpose of Review

    Fabry Disease (FD) is a rare lysosomal storage disorder characterised by multiorgan accumulation of glycosphingolipid due to...

    Ashwin Roy, Max J. Cumberland, ... Richard P. Steeds in Current Cardiology Reports
    Article Open access 12 April 2024
  13. Brain MRI correlations with disease burden and biomarkers in Fabry disease

    Objective

    To quantitatively evaluate cerebral small vessel disease (CSVD) in brain magnetic resonance imaging (MRI) and its correlation with disease...

    Yawen Zhao, Ying Zhu, ... Yining Huang in Journal of Neurology
    Article Open access 25 June 2023
  14. Management of pain in Fabry disease in the UK clinical setting: consensus findings from an expert Delphi panel

    Background

    Fabry disease is a rare, X-linked inherited lysosomal storage disorder, that manifests as a heterogeneous disease with renal, cardiac and...

    Karolina M. Stepien, Alexander Broomfield, ... Uma Ramaswami in Orphanet Journal of Rare Diseases
    Article Open access 21 July 2023
  15. The prevalence of Fabry disease in a Turkish population with chronic kidney patients

    Background and objectives

    Fabry disease (FD) is an X-linked lysosomal storage disease with various clinical symptoms due to a deficiency of an enzyme...

    Özdem Kavraz Tomar, Ayşe Zeynep Bal, ... Seyit İbrahim Akdağ in International Urology and Nephrology
    Article 01 February 2023
  16. What should rheumatologists know about Gaucher disease and Fabry disease? Connecting the dots for an overview

    Gaucher and Fabry diseases are lysosomal storage disorders in which deficient enzyme activity leads to pathological accumulation of sphingolipids....

    Rafael Alves Cordeiro, Nilton Salles Rosa Neto, Henrique Ayres Mayrink Giardini in Advances in Rheumatology
    Article Open access 22 March 2024
  17. Fabry disease: a rare disorder calling for personalized medicine

    Fabry Disease (FD) is a genetic disease caused by a deficiency in the activity of lysosomal galactosidase A (α-GalA), an enzyme responsible for the...

    Sarah Lerario, Luigi Monti, ... Michele Provenzano in International Urology and Nephrology
    Article Open access 13 April 2024
  18. Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation

    Background and Objective

    Fabry disease (FD) is a rare lysosomal storage disorder caused by a deficiency of the enzyme α-galactosidase A (aGal A)....

    André B. P. van Kuilenburg, Carla E. M. Hollak, ... Mariana Papouchado in Drugs in R&D
    Article Open access 21 April 2023
  19. Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal

    As a slowly progressive form of hypertrophic cardiomyopathy (HCM), Anderson-Fabry disease (FD) resembles the phenotype of the most common sarcomeric...

    Annamaria Del Franco, Giulia Iannaccone, ... Iacopo Olivotto in Heart Failure Reviews
    Article 25 November 2023
  20. Patient with Fabry disease undergoing cardiac surgery: a word of caution

    Fabry disease (FD) is a rare genetic disorder that affects various organs and systems in the body. The disease is caused by a deficiency in the...

    Jelena Vuckovic, Anastazija Stojsic Milosavljevic, ... Lazar Velicki in Indian Journal of Thoracic and Cardiovascular Surgery
    Article 16 March 2024
Did you find what you were looking for? Share feedback.